Steve DeMartino
Analyst · Grand Slam Asset Management. Your line is open
Thanks, Bart. Good afternoon, everyone. First quarter 2017 net sales were 14 million compared to 14.4 million in the 2016 first quarter. The 3% decline in net sales resulted from lower restaurant solutions and casino and gaming sales, partially offset by an increase in both POS automation and banking sales and TransAct services group sales. First looking at our sales for the first quarter by market. Restaurant solutions sales were $527,000, down 36% or $295,000 from last year's first quarter. Sales in the quarter were impacted by a decline in sales to our distributor and as Bart noted, a shift in customer interest towards the new AccuDate XL, particularly following the recent announcement of our partnership with Jolt. As Bart noted, this new relationship with Jolt has driven many of our existing and potential customers to re-evaluate their buying decision, as they consider moving up to purchase the AccuDate XL instead of the AccuDate 9700 or PRO to gain the additional features and benefits the XL offers. Though this is having a temporary impact on our sales in the near term, we believe this shift in customer interest to the XL will bear fruit for TransAct in the long run. POS automation and banking sales were up 6% or $143,000 to 2.5 million in the 2017 first quarter, as we continued to benefit from strong shipments of our Ithaca 9000 printers to McDonald's for their many new initiatives. Casino and gaming sales were down 6% year-over-year or $321,000 to 5.1 million in the first quarter of ‘17. Domestic sales declined 7% from the prior year as increased casino printer shipments, including 2500 Epic 950s we shipped for the new ilani casino, up in the Washington State. We’re more than offset by a decline in Epicentral sales. In the prior year period, we completed two Epicentral system installations compared to no new installations in the first quarter of this year. International casino and gaming sales were also down to 5% year-over-year as continued strength in the European and Australian sports betting markets, a key use of our roll fed kiosk printers were more than offset by a decline in international casino printer shipments. Lottery sales of 3 million were relatively consistent with the 2.9 million we recorded in the first quarter last year. Printrex product sales were $178,000 compared to $155,000 in the 2016 first quarter. Though our sales continued to be negatively impacted by overall weakness in the oil and gas industry, we did finally begin to see some signs of life in this business during the first quarter. TSG sales were up 2% year-over-year to 2.7 million, as declining consumable sales for legacy POS and banking products that we are deemphasizing were more than offset by an increase in spare part sales to IGT for our installed base of lottery printers. We expect spare part sales to IGT to continue to be strong this year, particularly in the second half of the year. Gross margins for the first quarter improved to 43.5% from 41% in the first quarter of last year. Our quarterly gross margin benefited from higher spare parts sales as well as lower manufacturing overhead expenses. As we've said for some time now, TransAct’s gross margins will continue to expand over time, as we transition our business towards higher margin solutions like our AccuDate terminals and away from our legacy products and this shift in sales mix takes hold as we move through 2017. Total operating expenses for the first quarter of ’17 were 4.7 million, down 5% from the year ago period. Engineering design and product development expenses for the first quarter were down 243,000 or 20% year-over-year. The year ago period included a higher prototype and other hardware development expenses as well as higher expenses related to the completion of software development projects for Epicentral as well as our line of AccuDate products, all of which will directly support our sales growth going forward. Selling and marketing expenses for the first quarter were down $121,000 or 7% to 1.7 million, mostly driven by lower sales commissions and lower travel expenses. G&A expenses for the first quarter were $2 million, up 5% over the year ago period on higher professional service fees. Operating income for the first quarter of ’17 was 1.4 million or 10.1% of sales compared to the operating income of $900,000 or 6.5% of sales in the year ago quarter. So even on a 3% decline in sales in the quarter, we were still able to achieve a 51% increase in operating income. Diluted EPS for the 2017 first quarter increased 63% to $0.13 compared to $0.08 in the year ago period and our EBITDA for the first quarter of ’17 was 1.7 million compared to 1.3 million in the first quarter of ’16, up 36%. Now, turning to the balance sheet. We ended the quarter with 2.4 million of cash and no debt. We returned a total of approximately $600,000 of capital to our shareholders during the ’17 first quarter to our quarterly cash dividend of $0.08 per share. We didn’t repurchase any shares in the quarter, leaving us with approximately 1.4 million remaining under the $5 million buyback authorization we announced February last year. Also, as you may have seen earlier this week, our Board of Directors announced a $0.01 increase in our regular quarterly dividend from $0.08 to $0.09 per share, beginning this quarter. This represents a 12.5% increase in our quarterly dividend, bringing the yield to 4%, based on today's closing stock price. We believe this is a strong indication of our confidence in the future outlook for TransAct, particularly as we pursue growth in the very exciting AccuDate restaurant solutions market. And finally, I'd like to discuss the timing and amount of the increased AccuDate related spend this year. Based in part on the updated timing of this plan spend, we now expect operating expenses, particularly selling and marketing expenses, to rise approximately 1.5 million year-over-year, compared to our prior expectation that such expenses will increase by about $2 million. Given the timing of hiring a direct sales force as well as the strategic decision to push the AccuDate marketing campaign closer to the start of the NRA show that takes place later this month, we now expect to incur the bulk of these expenses during the second and third quarters of this year. As a result, we expect this spend to have the most impact on our second and third quarter results. And at this point, I'd like to give the call back to Bart for some closing remarks. Bart?